What Happened?
, -based Appointed Richard McNaught as Sr. Director of Information Technology
About the Company
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is the global founder and leader in the new field of bioprognosisTM for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company`s lead product, KidneyIntelX, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
About the Person
Richard McNaught is Sr. Director of Information Technology at . Previously, Richard held various senior IT leadership roles in the industry.
Info Source
News
Short Profile